Status:
COMPLETED
Accurate Classification System for Patients With COVID-19 Pneumonitis
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
Pneumonitis
Eligibility:
All Genders
Brief Summary
The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-1...
Detailed Description
1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group. 2. Responsible for the ...
Eligibility Criteria
Inclusion
- Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.
Exclusion
- Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
- Suspected patient review refers to the negative nucleic acid test.
Key Trial Info
Start Date :
December 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 4 2020
Estimated Enrollment :
669 Patients enrolled
Trial Details
Trial ID
NCT04302688
Start Date
December 10 2019
End Date
March 4 2020
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430060